Fast Market Research

MicroDose Therapeutx, Inc. - Product Pipeline Review - 2013 - New Report Available

New Pharmaceuticals research report from Global Markets Direct is now available from Fast Market Research


Boston, MA -- (SBWIRE) -- 02/03/2014 -- Global Market Direct's pharmaceuticals report, "MicroDose Therapeutx, Inc. - Product Pipeline Review - 2013" provides data on the MicroDose Therapeutx, Inc.'s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct's proprietary databases, MicroDose Therapeutx, Inc.'s corporate website, SEC filings, investor presentations and featured press releases, both from MicroDose Therapeutx, Inc. and industry-specific third party sources, put together by Global Markets Direct's team.

View Full Report Details and Table of Contents


- MicroDose Therapeutx, Inc. - Brief MicroDose Therapeutx, Inc. overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of MicroDose Therapeutx, Inc. human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of MicroDose Therapeutx, Inc. with complete description of the product's developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the MicroDose Therapeutx, Inc.'s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.

Reasons to Get This Report

- Evaluate MicroDose Therapeutx, Inc.'s strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of MicroDose Therapeutx, Inc. in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the MicroDose Therapeutx, Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with MicroDose Therapeutx, Inc..
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of MicroDose Therapeutx, Inc. and identify potential opportunities in those areas.

Companies Mentioned in this Report: MicroDose Therapeutx, Inc.

About Fast Market Research
Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget. For more information about these or related research reports, please visit our website at or call us at 1.800.844.8156.

Browse all Pharmaceuticals research reports at Fast Market Research

You may also be interested in these related reports:

- MicroDose Therapeutx, Inc. - Product Pipeline Review - 2012
- Irritable Bowel Syndrome - Pipeline Review, H2 2013
- Constipation - Pipeline Review, H2 2013
- Raynauds Disease - Pipeline Review, H2 2013
- Organophosphate And Carbamate Poisoning - Pipeline Review, H2 2013
- Constipation - Pipeline Review, H1 2013
- Type 2 Diabetes - Pipeline Review, H2 2013
- Hanmi Pharmaceuticals, Co. Ltd. - Product Pipeline Review - 2013
- Hypertension - Pipeline Review, H2 2013
- Novo Nordisk A/S - Product Pipeline Review - 2013